FDA grants Otsuka’s Sibeprenlimab breakthrough therapy designation in IgAN

Pallavi Madhiraju- February 17, 2024 0

In a significant development for the treatment of kidney disease, the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sibeprenlimab, an ... Read More

Novartis acquires kidney disease innovator Chinook Therapeutics

Pallavi Madhiraju- August 14, 2023 0

Swiss pharmaceutical giant Novartis has wrapped up the previously announced $3.5 billion acquisition of Seattle-based biopharmaceutical firm Chinook Therapeutics, Inc. This deal propels Novartis deeper ... Read More

FDA approves Gilead’s Veklury for COVID-19 patients with severe renal impairment

Pallavi Madhiraju- July 14, 2023 0

Gilead Sciences said that the US Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Veklury (remdesivir) usage in COVID-19 ... Read More

ProKidney to acquire manufacturing facility in North Carolina for REACT commercial production

Pallavi Madhiraju- June 13, 2023 0

ProKidney, a late clinical-stage cellular therapeutics company, has announced plans to acquire a 210,000 square foot facility and approximately 22 acres of land in Greensboro, ... Read More

Novartis to expand renal portfolio with Chinook Therapeutics acquisition

Pallavi Madhiraju- June 12, 2023 0

Novartis has announced its agreement to acquire Chinook Therapeutics, a clinical stage biopharmaceutical company based in Seattle, Washington in a deal worth up to around ... Read More

AstraZeneca wraps up $1.8bn acquisition of CinCor Pharma

Raghuram Kadari- February 28, 2023 0

AstraZeneca has closed the previously announced $1.8 billion acquisition of US biopharmaceutical company CinCor Pharma. Under the terms of the agreement, AstraZeneca acquired all outstanding ... Read More

GSK gets Jesduvroq FDA approval for anaemia of chronic kidney disease

Raghuram Kadari- February 4, 2023 0

GSK has secured the approval of the US Food and Drug Administration (FDA) for the company’s Jesduvroq (daprodustat) for anaemia of chronic kidney disease (CKD) ... Read More

AstraZeneca to acquire US biopharma company CinCor Pharma for $1.8bn

Raghuram Kadari- January 10, 2023 0

AstraZeneca has agreed to acquire CinCor Pharma for a transaction value of around $1.8 billion, which includes an upfront cash payment of about $1.3 billion, ... Read More

AstraZeneca Pharma India gets Dapagliflozin 10mg import and market permission from CDSCO

Pallavi Madhiraju- November 27, 2022 0

AstraZeneca Pharma India has secured an import and market permission for Dapagliflozin (Forxiga) tablets of 10 mg from India’s Central Drugs Standard Control Organisation (CDSCO), ... Read More

Astellas, FibroGen get extended Roxadustat approval in Japan for anemia of CKD

pharmanewsdaily- November 28, 2020 0

Roxadustat approval - Astellas Pharma and FibroGen have secured approval for EVRENZO (roxadustat) in Japan for the treatment of anemia associated with chronic kidney disease ... Read More